Acadia Pharmaceuticals Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2008 | — | $53.0M | $21.2M |
| FY2009 | — | $12.1M | $18.1M |
| FY2010 | — | $29.7M | $6.8M |
| FY2011 | — | $23.4M | $6.9M |
| FY2012 | — | $85.0M | $57.9M |
| FY2013 | — | $182.1M | $11.7M |
| FY2014 | — | $309.5M | $61.9M |
| FY2015 | — | $199.8M | $102.1M |
| FY2016 | — | $518.4M | $163.6M |
| FY2017 | — | $335.3M | $69.4M |
| FY2018 | — | $479.1M | $134.8M |
| FY2019 | — | $699.1M | $189.7M |
| FY2020 | — | $627.0M | $326.0M |
| FY2021 | — | $540.9M | $147.4M |
| FY2022 | — | $400.4M | $114.8M |
| FY2023 | — | $431.8M | $188.7M |
| FY2024 | — | $732.8M | $319.6M |
| FY2025 | — | $1.23B | $177.7M |